Implementing combinatorial immunotherapeutic regimens against cancer
Researchers release the brakes on the immune | EurekAlert!
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
Tückischen Blutkrebs effektiv bekämpfen — Universität Bonn
Erfolg bei Ausschreibung? Advanced Clinician Scientist? – Forschende Mediziner erhalten Förderung durch das BMBF - MINQ Magazin
Advances in Immunotherapy of Chronic Myeloid Leukemia CML
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Loop | Annkristin Heine
UKB NewsRoom | Annkristin Heine
6 "Ann Grobe" profiles | LinkedIn
Tumor rejection in Cblb−/− mice depends on IL-9 and Th9 cells | Journal for ImmunoTherapy of Cancer
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie der Universitätsklinikum Bonn
Clinical Case Reports: Vol 9, No 9
Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors
PDF) Clinical and immunological effects of mRNA vaccines in malignant diseases
ImmunoSensation / The Immune Sensory System » Details
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient. - Abstract - Europe PMC
Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imagin
AG Heine - Hämatologie und Onkologie der Universitätsklinikum Bonn
Two cases of EBV infection preceding lymphoma | SpringerLink
Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells | BMC Biology | Full Text
Liebe Leserin, lieber Leser,
Prolonged IKKβ Inhibition Improves Ongoing CTL Antitumor Responses by Incapacitating Regulatory T Cells - ScienceDirect
Medicine®
